Cargando…

Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011–2019

BACKGROUND: Respiratory syncytial virus (RSV) is the leading cause of hospitalizations in United States infants aged <1 year, but research has focused on select populations. METHODS: National (Nationwide) Inpatient Sample and National Emergency Department (ED) Sample data (2011–2019) were used to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suh, Mina, Movva, Naimisha, Jiang, Xiaohui, Reichert, Heidi, Bylsma, Lauren C, Fryzek, Jon P, Nelson, Christopher B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Supplement Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377028/ https://www.ncbi.nlm.nih.gov/pubmed/35968879 http://dx.doi.org/10.1093/infdis/jiac155

Ejemplares similares

Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009–2019: A Study of the National (Nationwide) Inpatient Sample
por: Suh, Mina, et al.
Publicado: (2022)

Mortality Associated With Respiratory Syncytial Virus, Bronchiolitis, and Influenza Among Infants in the United States: A Birth Cohort Study From 1999 to 2018
por: Reichert, Heidi, et al.
Publicado: (2022)

A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year( )
por: Suh, Mina, et al.
Publicado: (2022)

Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age
por: Movva, Naimisha, et al.
Publicado: (2022)

Mortality Among US Infants and Children Under 5 Years of Age with Respiratory Syncytial Virus and Bronchiolitis: A Systematic Literature Review
por: Bylsma, Lauren C, et al.
Publicado: (2022)

Respiratory Syncytial Virus During the COVID-19 Pandemic Compared to Historic Levels: A Retrospective Cohort Study of a Health System( )
por: Movva, Naimisha, et al.
Publicado: (2022)

1508. Hospitalizations and Emergency Department Visits for Respiratory Syncytial Virus Among Infants Aged < 1 year in the United States: An Analysis of Nationwide Inpatient and Emergency Room Data
por: Suh, Mina, et al.
Publicado: (2020)

1636. Prevention of respiratory syncytial virus hospitalizations (RSVH) in US infants who paid through Medicaid would have a disproportionate benefit for Black, Hispanic, Asian/Pacific Islander, Native American and Other race/ethnicity infants, and have a substantial impact on overall RSVH burden and related costs: Rates of respiratory syncytial virus hospitalization (RSVH) among US infants by race/ethnicity and insurance payer, NIS 2018-2020
por: Nelson, Christopher B, et al.
Publicado: (2023)

Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997–2012
por: Doucette, Abigail, et al.
Publicado: (2016)

Respiratory Syncytial Virus and All-Cause Bronchiolitis Hospitalizations Among Preterm Infants Using the Pediatric Health Information System (PHIS)
por: Fergie, Jaime, et al.
Publicado: (2020)

Theoretical attributable risk analysis and Disability Adjusted Life Years (DALYs) based on increased dairy consumption
por: Cohen, Sarah S., et al.
Publicado: (2022)

Systematic Literature Review of the Prevalence and Prognostic Value of Delta-Like Ligand 3 Protein Expression in Small Cell Lung Cancer
por: Bylsma, Lauren C., et al.
Publicado: (2023)

1406. Comparison of Clinical Presentations and Burden of Respiratory Syncytial Virus in Infants Across Three Distinct Healthcare Settings
por: Rankin, Danielle A, et al.
Publicado: (2020)

Interferon gamma expression and mortality in unselected cohorts of urothelial bladder cancer patients
por: Gillezeau, Christina, et al.
Publicado: (2022)

Immunoprophylaxis of respiratory syncytial virus: global experience
por: Simoes, Eric AF
Publicado: (2002)

Scoping Review of Employer-Led Research Using Employee Health Claims Data
por: Movva, Naimisha, et al.
Publicado: (2023)

1520. Respiratory Syncytial Virus Hospitalizations (RSVH) and All-Cause Bronchiolitis Hospitalizations (BH) Among Children Aged ≤ 24 Months at the Start of RSV Season With Bronchopulmonary Dysplasia/Chronic Lung Disease of Prematurity (BPD/CLDP) Before and After the 2014 American Academy of Pediatrics (AAP) Policy
por: Fergie, Jaime, et al.
Publicado: (2020)

1513. Medically Attended Respiratory Syncytial Virus Hospitalizations (RSVH) and All-Cause Bronchiolitis Hospitalizations (BH) Among Children Aged ≤ 24 Months at RSV Season Start With Higher-Risk Congenital Heart Disease (CHD) Before and After the 2014 American Academy of Pediatrics (AAP) Policy
por: Fergie, Jaime, et al.
Publicado: (2020)

The Burden of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Synthesis
por: Simões, Eric A F
Publicado: (2022)

An epidemiological study of respiratory syncytial virus associated hospitalizations in Denmark
por: Stensballe, Lone Graff
Publicado: (2002)

Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing
por: Kimpen, Jan LL
Publicado: (2002)

The Burden of Respiratory Syncytial Virus in Children Under 2 Years of Age in a Rural Community in Maharashtra, India
por: Satav, Ashish, et al.
Publicado: (2021)

Comparison of clinical presentations and burden of respiratory syncytial virus in infants across three distinct healthcare settings in Davidson County, Tennessee
por: Rankin, Danielle A., et al.
Publicado: (2022)

Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link
por: Piedimonte, Giovanni
Publicado: (2002)

Potential therapeutic implications of new insights into respiratory syncytial virus disease
por: Openshaw, Peter JM
Publicado: (2002)

Cost of Respiratory Syncytial Virus Infections in US Infants: Systematic Literature Review and Analysis
por: Bowser, Diana M, et al.
Publicado: (2022)

Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease
por: Sigurs, Nele
Publicado: (2002)

Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies
por: Srikantiah, Padmini, et al.
Publicado: (2021)

World Health Organization Influenza-Like Illness Underestimates the Burden of Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults
por: Korsten, Koos, et al.
Publicado: (2021)

Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997–2012
por: Pastula, Susan T., et al.
Publicado: (2017)

Impact of Respiratory Syncytial Virus on Child, Caregiver, and Family Quality of Life in the United States: Systematic Literature Review and Analysis( )
por: Glaser, Elizabeth L, et al.
Publicado: (2022)

Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses
por: Friedman, Deborah, et al.
Publicado: (2017)

Introduction. RSV and RAD: possibilities for prevention? The link between respiratory syncytial virus and reactive airway disease
por: Carbonell-Estrany, Xavier, et al.
Publicado: (2002)

Abstracts from Rambam Research Day, December 29, 2011
Publicado: (2012)

Economic Burden of Multiple Sclerosis Drugs in Iran during 2011–2019
por: Asadollahi, Mina, et al.
Publicado: (2023)

All Infants Are at Risk of Developing Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection and Deserve Protection
por: Hodges, Erin N, et al.
Publicado: (2022)

Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics
por: Simões, Eric A. F., et al.
Publicado: (2015)

PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study
por: Cronin-Fenton, Deirdre, et al.
Publicado: (2021)

Estimates of HIV burden in emergencies
por: Lowicki-Zucca, M, et al.
Publicado: (2008)

“It’s Time to Represent”: shifting the paradigm to improve the quality of inputs into value assessment frameworks
por: Moczygemba, Leticia R, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8ud56nonv06u1qip9248j5dk50